| PI4KB | PIK | Atypical | 4d0m | g | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9146 | |
| PI4K2A | PIK | Atypical | 5eut | A | | - | Human | 9264 | |
| PIK3CG (p110g) | PIK | Atypical | 3nzs | A | | 6-(1,1-dioxidothiomorpholin-4-yl)-n-(3-methoxyphenyl)-1-methyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 9179 | |
| TRRAP | PIKK | Atypical | 8xvg | A | B | adenosine-5'-diphosphate | Human | 15323 | |
| PIK3CA (p110a) | PIK | Atypical | 8twy | A | | 1-(4-{[2-(4-{(4p)-4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-[(3s)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethoxy]methyl}piperidin-1-yl)prop-2-en-1-one | Human | 15392 | |
| PI4KB | PIK | Atypical | 8vof | A | | methyl 2-chloro-5-(methyl{(8r)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carbonyl}amino)benzoate | Human | 15377 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k11 | A | | - | Human | 13208 | |
| PIK3CA (p110a) | PIK | Atypical | 8exo | A | B | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | 14534 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 5luq | B | | - | Human | 9319 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7sgl | A | B | adenosine-5'-triphosphate | Human | 14062 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsp | A | | phosphothiophosphoric acid-adenylate ester | Human | 9106 | |
| PIK3CA (p110a) | PIK | Atypical | 8exl | A | A | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 14537 | |
| PIK3CA (p110a) | PIK | Atypical | 8exo | A | A | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | 14541 | |
| PIK3CA (p110a) | PIK | Atypical | 8exv | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14542 | |
| PIK3CD (p110d) | PIK | Atypical | 5m6u | A | | 4-azanyl-6-[[(1~{s})-1-(4-oxidanylidene-3-phenyl-pyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile | Human | 9094 | |
| PIK3CA (p110a) | PIK | Atypical | 8gud | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14535 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7sud | A | A | adenosine-5'-triphosphate | Human | 14055 | |
| PIK3CG (p110g) | PIK | Atypical | 7mez | A | | - | Human | 13798 | |
| PIK3CG (p110g) | PIK | Atypical | 4kzc | A | | n-{6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]imidazo[1,2-a]pyridin-2-yl}acetamide | Human | 9224 | |
| PIK3CG (p110g) | PIK | Atypical | 5g2n | A | | 2-azanyl-~{n}-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide | Human | 9206 | |
| PIK3CG (p110g) | PIK | Atypical | 5kae | A | | 4-azanyl-6-[[(1~{s})-1-(6-fluoranyl-3-phenyl-4-piperazin-1-ylcarbonyl-quinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile | Human | 9241 | |
| PIK3CG (p110g) | PIK | Atypical | 4ezk | A | | 2-(1-{[2-(2h-indazol-4-yl)-4-(morpholin-4-yl)pyrido[3,2-d]pyrimidin-6-yl]methyl}piperidin-4-yl)propan-2-ol | Human | 9176 | |
| PIK3CG (p110g) | PIK | Atypical | 5g55 | A | | 6-cyano-4-[[(1r)-1-(4-methylphenyl)ethyl]amino]quinoline-3-carboxamide | Human | 9199 | |
| PIK3CG (p110g) | PIK | Atypical | 4urk | A | | 2-[[(1r)-1-(7-methyl-2-morpholin-4-yl-4-oxidanylidene-pyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid | Human | 9196 | |
| PIK3CG (p110g) | PIK | Atypical | 4fjz | A | | 1'-[7-fluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-yl]-6'-(morpholin-4-yl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] | Human | 9173 | |
| PIK3CG (p110g) | PIK | Atypical | 6c1s | A | | {4-[2-(5,6-dimethoxypyridin-3-yl)-5-oxo-5,7-dihydro-6h-pyrrolo[3,4-b]pyridin-6-yl]-1h-pyrazol-1-yl}acetonitrile | Human | 10037 | |
| PIK3CG (p110g) | PIK | Atypical | 4dk5 | A | | 4-(2-[(6-methoxypyridin-3-yl)amino]-5-{[4-(methylsulfonyl)piperazin-1-yl]methyl}pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine | Human | 9232 | |
| PIK3CG (p110g) | PIK | Atypical | 1e8z | A | | staurosporine | Human | 9228 | |
| PIK3CG (p110g) | PIK | Atypical | 3qk0 | A | | n-[6-(6-chloro-5-{[(4-fluorophenyl)sulfonyl]amino}pyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide | Human | 9213 | |
| PIK3CG (p110g) | PIK | Atypical | 3l08 | A | A | 2,4-difluoro-n-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide | Human | 9217 | |
| PIK3CG (p110g) | PIK | Atypical | 3apc | A | | 5-(7-methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5h-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine | Human | 9231 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg6 | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14348 | |
| PIK3CG (p110g) | PIK | Atypical | 6xrl | A | | 2-amino-n-[(1s)-1-{8-[(1-methyl-1h-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl}ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide | Human | 12774 | |
| PIK3CG (p110g) | PIK | Atypical | 5jha | A | | [1-{4-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-6-(morpholin-4-yl)pyrimidin-2-yl}-3-(chloromethyl)azetidin-3-yl]methanol | Human | 9246 | |
| PIK3CG (p110g) | PIK | Atypical | 6t3c | A | | 7-methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one | Human | 11907 | |
| PIK3CG (p110g) | PIK | Atypical | 3zw3 | A | | n-{6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]imidazo[1,2-a]pyridin-2-yl}acetamide | Human | 9207 | |
| PIK3C3 | PIK | Atypical | 4oys | A | | (8s)-9-[(5-chloranylpyridin-3-yl)methyl]-2-[(3r)-3-methylmorpholin-4-yl]-8-(trifluoromethyl)-6,7,8,9a-tetrahydro-3h-pyrimido[1,2-a]pyrimidin-4-one | Human | 9327 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7z87 | A | A | (~{s})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol | Human | 14592 | |
| PIK3C3 | PIK | Atypical | 7rsj | A | B | n-{4-[(7r,8r)-4-oxo-7-(propan-2-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl]pyridin-2-yl}cyclopropanecarboxamide | Human | 13982 | |
| PIK3C3 | PIK | Atypical | 3ls8 | A | A | - | Human | 9340 | |
| PIK3C3 | PIK | Atypical | 6i3u | A | | 2-morpholin-4-yl-6-[7-[(2~{r})-1-morpholin-4-ylpropan-2-yl]oxy-9~{h}-thioxanthen-4-yl]pyran-4-one | Human | 11292 | |
| PIK3C3 | PIK | Atypical | 7rsv | A | A | (5as,8ar,9s)-2-[(3r)-3-methylmorpholin-4-yl]-5,5a,6,7,8,8a-hexahydro-4h-cyclopenta[e]pyrazolo[1,5-a]pyrazin-4-one | Human | 13985 | |
| PIK3C3 | PIK | Atypical | 3ihy | A | | - | Human | 9341 | |
| PIK3C3 | PIK | Atypical | 3ihy | C | | - | Human | 9331 | |
| PIK3C3 | PIK | Atypical | 5anl | A | | (8s)-2-(morpholin-4-yl)-9-[2-(propan-2-yloxy)ethyl]-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4h-pyrimido[1,2-a]pyrimidin-4-one | Human | 9349 | |
| PIK3C3 | PIK | Atypical | 3ls8 | A | B | - | Human | 9348 | |
| PIK3C3 | PIK | Atypical | 3ihy | D | | - | Human | 9337 | |
| PIK3C3 | PIK | Atypical | 4ph4 | B | B | - | Human | 9330 | |
| PIK3C3 | PIK | Atypical | 7rsp | A | B | (7r,8r)-2-[(3r)-3-methylmorpholin-4-yl]-7-(propan-2-yl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one | Human | 13986 | |
| SMG1 | PIKK | Atypical | 6l53 | A | | - | Human | 12156 | |
| PIK3CG (p110g) | PIK | Atypical | 6xrn | A | | 2-amino-5-{2-[(1s)-1-cyclopropylethyl]-7-methyl-1-oxo-2,3-dihydro-1h-isoindol-5-yl}-n-(trans-3-hydroxycyclobutyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide | Human | 13954 | |
| PIK3CA (p110a) | PIK | Atypical | 7mlk | A | A | 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide | Human | 14216 | |
| PI4KB | PIK | Atypical | 8q6g | A | B | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Human | 15012 | |
| PI4KB | PIK | Atypical | 8q6g | A | A | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Human | 15014 | |
| PI4KB | PIK | Atypical | 8q6g | A | C | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Human | 15016 | |
| PIK3CA (p110a) | PIK | Atypical | 7tz7 | A | A | (4s,5r)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one | Human | 14223 | |
| PIK3CG (p110g) | PIK | Atypical | 3pre | A | | 2-amino-8-(trans-4-methoxycyclohexyl)-4-methyl-6-(1h-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9198 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsd | A | | - | Human | 15090 | |
| PI4KB | PIK | Atypical | 8q6h | A | B | 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Human | 15017 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8h | A | | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | 15249 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7su3 | A | B | adenosine-5'-triphosphate | Human | 14053 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k17 | B | | - | Human | 13212 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7oty | A | | (~{s})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol | Human | 14057 | |
| ATM | PIKK | Atypical | 7ni4 | A | | 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoranyl-5-methoxy-pyridin-4-yl)-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one | Human | 13864 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7otm | A | | 8-(dibenzo[b,d]thiophen-4-yl)-2-(morpholin-4-yl)-4h-chromen-4-one | Human | 14061 | |
| PIK3CA (p110a) | PIK | Atypical | 7myn | A | B | - | Human | 13964 | |
| PIK3C3 | PIK | Atypical | 7rsp | A | A | (7r,8r)-2-[(3r)-3-methylmorpholin-4-yl]-7-(propan-2-yl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one | Human | 13981 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 8ezb | C | | adenosine-5'-triphosphate | Human | 14798 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8i | A | | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | 15248 | |
| ATR | PIKK | Atypical | 9zd1 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15662 | |
| ATR | PIKK | Atypical | 23fd | A | | phosphothiophosphoric acid-adenylate ester | Human | 15663 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8u | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 15250 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8v | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 15252 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8j | A | | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | 15251 | |
| MTOR (FRAP) | PIKK | Atypical | 9tds | A | | - | Human | 15768 | |
| MTOR (FRAP) | PIKK | Atypical | 9t92 | A | | - | Human | 15765 | |
| MTOR (FRAP) | PIKK | Atypical | 9ed7 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15766 | |
| MTOR (FRAP) | PIKK | Atypical | 9t93 | A | | - | Human | 15767 | |
| MTOR (FRAP) | PIKK | Atypical | 9zbj | A | | - | Human | 15769 | |
| MTOR (FRAP) | PIKK | Atypical | 9zbk | A | | - | Human | 15770 | |
| MTOR (FRAP) | PIKK | Atypical | 9t7j | A | | adenosine-5'-triphosphate | Human | 15771 | |
| MTOR (FRAP) | PIKK | Atypical | 9tdt | A | | - | Human | 15772 | |
| MTOR (FRAP) | PIKK | Atypical | 8rch | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15773 | |
| MTOR (FRAP) | PIKK | Atypical | 9tpw | A | | - | Human | 15774 | |
| TRRAP | PIKK | Atypical | 9rdk | E | | - | Human | 15849 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9iax | A | | - | Human | 16042 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9zob | A | | - | Human | 16043 | |
| RIOK3 | RIO | Atypical | 8zdd | I | | - | Human | 16169 | |
| PIK3CD (p110d) | PIK | Atypical | 5ubt | A | | 1-[4-(3-{4-amino-5-[1-(oxan-4-yl)-1h-pyrazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)piperazin-1-yl]ethan-1-one | Human | 9092 | |
| PIK3CD (p110d) | PIK | Atypical | 6pyr | A | B | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | 11546 | |
| PI4KAP2 | PIK | Atypical | 9b9g | A | A | - | Human | 16198 | |
| PI4KAP2 | PIK | Atypical | 9bax | B | | - | Human | 16199 | |
| PI4KAP2 | PIK | Atypical | 9b9g | A | B | - | Human | 16200 | |
| PI4KAP2 | PIK | Atypical | 9ot6 | A | | - | Human | 16201 | |
| PIK3CD (p110d) | PIK | Atypical | 6ocu | A | | 5-{(3r)-3-methyl-4-[(1r,2r)-2-methylcyclopropane-1-carbonyl]piperazin-1-yl}-3-(1-methyl-1h-pyrazol-4-yl)pyrazine-2-carbonitrile | Human | 11864 | |
| PIK3CA (p110a) | PIK | Atypical | 4ovu | A | B | - | Human | 9271 | |
| PIK3CA (p110a) | PIK | Atypical | 6pys | A | B | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | 11576 | |
| PIK3CA (p110a) | PIK | Atypical | 4ovv | A | | - | Human | 9307 | |
| PIK3CA (p110a) | PIK | Atypical | 7mlk | A | B | 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide | Human | 14217 | |
| PIK3CA (p110a) | PIK | Atypical | 4ovu | A | A | - | Human | 9291 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxb | A | | - | Human | 9282 | |
| PIK3CA (p110a) | PIK | Atypical | 5swo | A | | - | Human | 9303 | |
| PIK3CD (p110d) | PIK | Atypical | 6pyr | A | A | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | 11547 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7tyr | A | B | - | Human | 14321 | |
| PIK3CG (p110g) | PIK | Atypical | 3t8m | A | | n~2~-{2-chloro-4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}-n~2~,n~8~-dimethyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide | Human | 9186 | |
| PIK3CG (p110g) | PIK | Atypical | 3ps6 | A | | 4-amino-n-(6-methoxypyridin-3-yl)-2-methylquinazoline-8-carboxamide | Human | 9170 | |
| PIK3CG (p110g) | PIK | Atypical | 2chw | A | | 2-((9h-purin-6-ylthio)methyl)-5-chloro-3-(2-methoxyphenyl)quinazolin-4(3h)-one | Human | 9182 | |
| PIK3CG (p110g) | PIK | Atypical | 3zvv | A | | 5,7-dimethylpyrazolo[1,5-a]pyrimidin-2-amine | Human | 9172 | |
| PIK3CG (p110g) | PIK | Atypical | 3ene | A | | 1-methyl-3-naphthalen-2-yl-1h-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 9188 | |
| PIK3CG (p110g) | PIK | Atypical | 3lj3 | A | | (2z)-4,6-dihydroxy-2-{[1-methyl-4-(4-methylpiperazin-1-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl]methylidene}-1-benzofuran-3(2h)-one | Human | 9214 | |
| PIK3CG (p110g) | PIK | Atypical | 6fh5 | A | | 3-methyl-1-(oxan-4-yl)-8-pyridin-3-yl-imidazo[4,5-c]quinolin-2-one | Human | 10883 | |
| PIK3CG (p110g) | PIK | Atypical | 2chz | A | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9251 | |
| PIK3CG (p110g) | PIK | Atypical | 6aud | A | B | 10-[(s)-(1-tert-butylpiperidin-4-yl)sulfinyl]-2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | Human | 9216 | |
| PIK3CG (p110g) | PIK | Atypical | 4wwp | A | | n-{(1s)-1-[8-chloro-2-(2-methylpyridin-3-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine | Human | 9200 | |
| PIK3CG (p110g) | PIK | Atypical | 3apd | A | | 5-(2-morpholin-4-yl-7-pyridin-3-yl-6,7-dihydro-5h-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine | Human | 9205 | |
| PIK3CG (p110g) | PIK | Atypical | 7jwe | A | | gedatolisib | Human | 13412 | |
| PIK3CG (p110g) | PIK | Atypical | 3tl5 | A | | (2s)-1-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-2-hydroxypropan-1-one | Human | 9160 | |
| PIK3CG (p110g) | PIK | Atypical | 4ps8 | A | | n-[6-(5,6-dimethoxypyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide | Human | 9184 | |
| PIK3CG (p110g) | PIK | Atypical | 3prz | A | | 4-amino-2-methyl-n-(1h-pyrazol-3-yl)quinazoline-8-carboxamide | Human | 9210 | |
| PIK3CG (p110g) | PIK | Atypical | 3ibe | A | | 1-(4-{4-morpholin-4-yl-1-[1-(pyridin-3-ylcarbonyl)piperidin-4-yl]-1h-pyrazolo[3,4-d]pyrimidin-6-yl}phenyl)-3-pyridin-4-ylurea | Human | 9171 | |
| PIK3CG (p110g) | PIK | Atypical | 4fhj | A | | 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-n-(1h-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine | Human | 9209 | |
| PIK3CG (p110g) | PIK | Atypical | 5t23 | A | | 3-(benzotriazol-1-yl)-5-[1-methyl-5-[(1~{s})-1-morpholin-4-ylethyl]-1,2,4-triazol-3-yl]pyrazin-2-amine | Human | 9157 | |
| PIK3CG (p110g) | PIK | Atypical | 3oaw | A | | 2-amino-4-methyl-8-(1-methylethyl)-6-(1h-pyrazol-4-yl)pteridin-7(8h)-one | Human | 9240 | |
| PIK3CG (p110g) | PIK | Atypical | 3dpd | A | | 5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4h)-one | Human | 9159 | |
| PIK3CG (p110g) | PIK | Atypical | 4xz4 | A | | n-[5-(6-methoxypyrazin-2-yl)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl]acetamide | Human | 9194 | |
| PIK3CG (p110g) | PIK | Atypical | 3cst | A | | methylated ruthenium pyridocarbazole | Human | 9220 | |
| PIK3CG (p110g) | PIK | Atypical | 2v4l | A | | 3-[4-amino-1-(1-methylethyl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]phenol | Human | 9237 | |
| PIK3CG (p110g) | PIK | Atypical | 4anu | A | | 3-amino-n-methyl-6-[3-(1h-tetrazol-5-yl)phenyl]pyrazine-2-carboxamide | Human | 9162 | |
| PIK3CG (p110g) | PIK | Atypical | 3sd5 | A | | 5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine | Human | 9243 | |
| PIK3CG (p110g) | PIK | Atypical | 9gg9 | A | | 3-[(1~{s})-1-[4-azanyl-3-(3-fluoranyl-5-oxidanyl-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-4-phenyl-isochromen-1-one | Human | 15415 | |
| PIK3CG (p110g) | PIK | Atypical | 4anx | A | | 5-{3-[(4-{3-[4-(1-methylethyl)phenyl]pyrazin-2-yl}piperazin-1-yl)sulfonyl]phenyl}pyrimidin-2-amine | Human | 9252 | |
| PIK3CG (p110g) | PIK | Atypical | 3r7q | A | | n-(2-chlorophenyl)-n-methyl-4h-thieno[3,2-c]chromene-2-carboxamide | Human | 9227 | |
| PIK3CG (p110g) | PIK | Atypical | 6xrm | A | | 5-[2-amino-3-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-2-[(1s)-1-cyclopropylethyl]-7-(trifluoromethyl)-2,3-dihydro-1h-isoindol-1-one | Human | 12775 | |
| PIK3CG (p110g) | PIK | Atypical | 4anv | A | A | 2-{4-[(4'-methoxybiphenyl-3-yl)sulfonyl]piperazin-1-yl}-3-(4-methoxyphenyl)pyrazine | Human | 9195 | |
| PI4K2B | PIK | Atypical | 4wtv | B | B | adenosine-5'-triphosphate | Human | 9096 | |
| PIK3CG (p110g) | PIK | Atypical | 7jx0 | A | | n~3~-{[5-(4-acetylphenyl)-4-methyl-1,3-thiazol-2-yl]carbamoyl}-n-tert-butyl-beta-alaninamide | Human | 13411 | |
| PIK3CG (p110g) | PIK | Atypical | 4anw | A | B | 3-amino-6-{4-chloro-3-[(2,3-difluorophenyl)sulfamoyl]phenyl}-n-methylpyrazine-2-carboxamide | Human | 9175 | |
| PIK3CG (p110g) | PIK | Atypical | 3qaq | A | | [(4-{2-[(3-hydroxyphenyl)amino]-1h-benzimidazol-1-yl}-1,3,5-triazin-2-yl)amino]acetonitrile | Human | 9211 | |
| PIK3CG (p110g) | PIK | Atypical | 4flh | A | | 4-(2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-{(1r)-1-[4-(methylsulfonyl)piperazin-1-yl]ethyl}pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine | Human | 9212 | |
| PIK3CG (p110g) | PIK | Atypical | 1he8 | A | | - | Human | 9201 | |
| PIK3CG (p110g) | PIK | Atypical | 3l16 | A | | 5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyridin-2-amine | Human | 9233 | |
| PIK3CA (p110a) | PIK | Atypical | 8tgd | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14970 | |
| PIK3CA (p110a) | PIK | Atypical | 8tu6 | A | | - | Human | 14971 | |
| PIK3CA (p110a) | PIK | Atypical | 8ils | A | B | n-[(2r)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | 14968 | |
| PIK3CA (p110a) | PIK | Atypical | 8ilv | A | | n-[(2r)-1-(ethylamino)-1-oxidanylidene-3-[3-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | 14974 | |
| ATM | PIKK | Atypical | 8oxq | A | | phosphoaminophosphonic acid-adenylate ester | Human | 14990 | |
| ATM | PIKK | Atypical | 8oxp | A | | phosphoaminophosphonic acid-adenylate ester | Human | 14991 | |
| ATM | PIKK | Atypical | 6k9l | A | | - | Human | 11896 | |
| ATM | PIKK | Atypical | 8oxm | B | | phosphoaminophosphonic acid-adenylate ester | Human | 14992 | |
| ATM | PIKK | Atypical | 8oxo | B | | phosphoaminophosphonic acid-adenylate ester | Human | 14993 | |
| RIOK1 | RIO | Atypical | 6g5i | z | | - | Human | 10004 | |
| PIK3CG (p110g) | PIK | Atypical | 4ezl | A | | 2-(1-{[2-(2-aminopyrimidin-5-yl)-4-(morpholin-4-yl)pyrido[3,2-d]pyrimidin-6-yl]methyl}piperidin-4-yl)propan-2-ol | Human | 9235 | |
| PIK3CG (p110g) | PIK | Atypical | 4xx5 | A | | n-[5-(5-methoxypyridin-3-yl)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl]acetamide | Human | 9236 | |
| PIK3CG (p110g) | PIK | Atypical | 4ps7 | A | | n-[6-(pyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide | Human | 9163 | |
| PIK3CG (p110g) | PIK | Atypical | 3l54 | A | | 6-(1h-pyrazolo[3,4-b]pyridin-5-yl)-4-pyridin-4-ylquinoline | Human | 9197 | |
| PIK3CG (p110g) | PIK | Atypical | 3qar | A | | 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-n-(1h-pyrazol-3-yl)-1h-benzimidazol-2-amine | Human | 9178 | |
| PIK3CG (p110g) | PIK | Atypical | 4g11 | A | | 2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]-n-phenylacetamide | Human | 9223 | |
| PIK3C3 | PIK | Atypical | 5enn | B | A | 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methyl-propan-2-ol | Human | 9345 | |
| PIK3CD (p110d) | PIK | Atypical | 5dxu | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 9091 | |
| PI4KB | PIK | Atypical | 4d0m | C | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9153 | |
| PIK3CA (p110a) | PIK | Atypical | 8w9b | A | | - | Human | 15273 | |
| PIK3CA (p110a) | PIK | Atypical | 8w9a | A | | - | Human | 15274 | |
| PI4KB | PIK | Atypical | 4d0m | I | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9151 | |
| PI4KB | PIK | Atypical | 5fbw | A | | ~{n}-[2-[[6-chloranyl-3-[4-methoxy-3-[[(2~{r})-1-oxidanylbutan-2-yl]sulfamoyl]phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide | Human | 9149 | |
| SMG1 | PIKK | Atypical | 7pw9 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 14000 | |
| SMG1 | PIKK | Atypical | 7pw7 | A | | 1-[4-[4-[2-[[4-chloranyl-3-(diethylsulfamoyl)phenyl]amino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methyl-urea | Human | 14005 | |
| SMG1 | PIKK | Atypical | 7pw6 | A | | 1-[4-[4-[2-[[4-chloranyl-3-(diethylsulfamoyl)phenyl]amino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methyl-urea | Human | 14001 | |
| SMG1 | PIKK | Atypical | 6syt | A | | - | Human | 11866 | |
| PIK3CD (p110d) | PIK | Atypical | 8bcy | A | B | 9-[2-(3,4-dichlorophenyl)ethyl]-2-(3-hydroxyphenyl)-8-oxidanylidene-7~{h}-purine-6-carboxamide | Human | 14734 | |
| PIK3C3 | PIK | Atypical | 13bv | A | | - | Human | 15507 | |
| COQ8A (ADCK3) | ABC1 | Atypical | 4ped | A | B | - | Human | 9120 | |
| PIK3C3 | PIK | Atypical | 4uwk | A | B | - | Human | 9335 | |
| PIK3C3 | PIK | Atypical | 9mhg | B | | - | Human | 15508 | |
| PIK3C3 | PIK | Atypical | 7bl1 | B | | - | Human | 13361 | |
| PIK3C3 | PIK | Atypical | 9rx6 | A | | - | Human | 15509 | |
| PIK3C3 | PIK | Atypical | 9tw3 | A | | - | Human | 15510 | |
| PIK3C3 | PIK | Atypical | 4uwk | A | A | - | Human | 9342 | |
| PIK3C3 | PIK | Atypical | 9mhh | B | | - | Human | 15511 | |
| PIK3C3 | PIK | Atypical | 4uwh | A | A | - | Human | 9346 | |
| PIK3C3 | PIK | Atypical | 9rx8 | A | | - | Human | 15512 | |
| COQ8A (ADCK3) | ABC1 | Atypical | 5i35 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 9122 | |
| COQ8A (ADCK3) | ABC1 | Atypical | 4ped | A | A | - | Human | 9121 | |
| PIK3C3 | PIK | Atypical | 4uwg | A | A | - | Human | 9347 | |
| PIK3C3 | PIK | Atypical | 4uwf | A | | - | Human | 9328 | |
| PIK3C3 | PIK | Atypical | 9s47 | A | | - | Human | 15513 | |
| PIK3C3 | PIK | Atypical | 5enn | A | A | 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methyl-propan-2-ol | Human | 9343 | |
| PIK3C3 | PIK | Atypical | 9tz3 | A | | adenosine-5'-diphosphate | Human | 15514 | |
| PIK3C3 | PIK | Atypical | 5enn | B | B | 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methyl-propan-2-ol | Human | 9329 | |
| PIK3C3 | PIK | Atypical | 3ls8 | B | B | - | Human | 9339 | |
| PIK3C3 | PIK | Atypical | 4uwl | A | | - | Human | 9332 | |
| PIK3C3 | PIK | Atypical | 9rx7 | A | | - | Human | 15517 | |
| PIK3C3 | PIK | Atypical | 3ls8 | B | A | - | Human | 9333 | |
| ATM | PIKK | Atypical | 6k9l | B | | - | Human | 11895 | |
| PIK3C3 | PIK | Atypical | 9rxb | A | | - | Human | 15519 | |
| PIK3C3 | PIK | Atypical | 4uwh | A | B | - | Human | 9334 | |
| PIK3C3 | PIK | Atypical | 9rxa | A | | - | Human | 15518 | |
| PIK3C3 | PIK | Atypical | 4ph4 | B | A | - | Human | 9326 | |
| PIK3C3 | PIK | Atypical | 9rx9 | A | | - | Human | 15520 | |
| PIK3C3 | PIK | Atypical | 9rx5 | A | | - | Human | 15521 | |
| PIK3C3 | PIK | Atypical | 5enn | A | B | 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methyl-propan-2-ol | Human | 9338 | |
| SMG1 | PIKK | Atypical | 7pw5 | A | | 1-[4-[4-[2-[[4-chloranyl-3-(diethylsulfamoyl)phenyl]amino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methyl-urea | Human | 14002 | |
| SMG1 | PIKK | Atypical | 6l54 | A | | - | Human | 12155 | |
| SMG1 | PIKK | Atypical | 7pw4 | A | | 1-[4-[4-[2-[[4-chloranyl-3-(diethylsulfamoyl)phenyl]amino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methyl-urea | Human | 14003 | |
| SMG1 | PIKK | Atypical | 7pw8 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 14004 | |
| SMG1 | PIKK | Atypical | 6z3r | A | | phosphoaminophosphonic acid-adenylate ester | Human | 12630 | |
| PI4K2B | PIK | Atypical | 4wtv | A | B | adenosine-5'-triphosphate | Human | 9098 | |
| PI4K2B | PIK | Atypical | 8a5x | A | | 4-azanyl-7-[3-(hydroxymethyl)phenyl]quinazoline-6-carboxamide | Human | 14384 | |
| PI4K2B | PIK | Atypical | 4wtv | B | A | adenosine-5'-triphosphate | Human | 9097 | |
| MTOR (FRAP) | PIKK | Atypical | 5zcs | B | | - | Human | 9749 | |
| PI4K2A | PIK | Atypical | 5i0n | A | A | adenosine-5'-triphosphate | Human | 9260 | |
| PIK3CA (p110a) | PIK | Atypical | 5fi4 | A | B | ~{n}-[6-[5-azanyl-6-[(2~{s})-1,1,1-tris(fluoranyl)propan-2-yl]oxy-pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]ethanamide | Human | 9309 | |
| PI4KB | PIK | Atypical | 4d0m | M | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9138 | |
| PIK3CA (p110a) | PIK | Atypical | 8ow2 | A | A | - | Human | 14765 | |
| PIK3CG (p110g) | PIK | Atypical | 5oq4 | A | A | 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | Human | 9244 | |
| PI4KB | PIK | Atypical | 4d0m | S | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9142 | |
| PI4KB | PIK | Atypical | 4d0m | Y | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9133 | |
| PI4KB | PIK | Atypical | 6gl3 | A | | (3~{s})-4-(6-azanyl-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl)-~{n}-(4-methoxy-2-methyl-phenyl)-3-methyl-piperazine-1-carboxamide | Human | 10442 | |
| PI4KB | PIK | Atypical | 4d0l | A | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9152 | |
| PI4KB | PIK | Atypical | 5euq | E | | ~{n}-[5-[3-[[(4-hydroxyphenyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-4-methoxy-phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide | Human | 9132 | |
| PI4KB | PIK | Atypical | 4wae | A | | adenosine-5'-triphosphate | Human | 9144 | |
| PI4KB | PIK | Atypical | 4d0m | A | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9136 | |
| PI4KB | PIK | Atypical | 5fbv | A | | ~{n}-[2-[[6-chloranyl-3-[3-(2-hydroxyethylsulfamoyl)-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide | Human | 9147 | |
| PI4KB | PIK | Atypical | 4d0l | C | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9143 | |
| PI4KB | PIK | Atypical | 5fbl | A | | ~{n}-[2-[[6-chloranyl-3-(4-methoxy-3-morpholin-4-ylsulfonyl-phenyl)-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide | Human | 9150 | |
| PI4KB | PIK | Atypical | 8q6h | A | A | 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Human | 15015 | |
| PI4KB | PIK | Atypical | 4d0m | Q | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9145 | |
| PI4KB | PIK | Atypical | 5fbr | A | | ~{n}-[2-[[3-[3-[(4-azanylcyclohexyl)sulfamoyl]-4-methoxy-phenyl]-6-chloranyl-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide | Human | 9140 | |
| PI4KB | PIK | Atypical | 8q6f | A | C | 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-2,5-dimethyl-7-(pyridin-4-ylmethylamino)pyrazolo[1,5-a]pyrimidine | Human | 15011 | |
| PIK3C3 | PIK | Atypical | 3ihy | B | | - | Human | 9336 | |
| PIK3C3 | PIK | Atypical | 3ihy | E | | - | Human | 9344 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zh2 | A | | - | Human | 12927 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7su3 | A | A | adenosine-5'-triphosphate | Human | 14058 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zhe | A | | - | Human | 12928 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7sgl | A | A | adenosine-5'-triphosphate | Human | 14059 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zh6 | A | | - | Human | 12929 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7sud | A | B | adenosine-5'-triphosphate | Human | 14060 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7z87 | A | B | (~{s})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol | Human | 14593 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7otv | A | | (1s,6br,9as,11r,11br)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3h-furo[4,3,2-de]indeno[4,5-h][2]benzopyran-11-yl acetate | Human | 14063 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7nfc | A | | - | Human | 13852 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zha | A | | - | Human | 12931 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7z88 | A | | (~{s})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol | Human | 14594 | |
| ATM | PIKK | Atypical | 7ni6 | A | | phosphothiophosphoric acid-adenylate ester | Human | 13862 | |
| ATM | PIKK | Atypical | 5np0 | B | | - | Human | 9266 | |
| ATM | PIKK | Atypical | 7sic | A | | phosphoaminophosphonic acid-adenylate ester | Human | 14101 | |
| ATM | PIKK | Atypical | 5np0 | A | | - | Human | 9267 | |
| PIK3CG (p110g) | PIK | Atypical | 8dp0 | A | | - | Human | 14838 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsc | A | | - | Human | 15084 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsb | A | | - | Human | 15085 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsa | A | | - | Human | 15087 | |
| PIK3CA (p110a) | PIK | Atypical | 8ts7 | A | | - | Human | 15088 | |
| PIK3CA (p110a) | PIK | Atypical | 8ts9 | A | | - | Human | 15089 | |
| ATM | PIKK | Atypical | 7ni5 | A | | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | Human | 13863 | |
| ATM | PIKK | Atypical | 6k9k | A | | - | Human | 11897 | |
| ATR | PIKK | Atypical | 9l4d | A | | camonsertib | Human | 15644 | |
| ATR | PIKK | Atypical | 23fc | A | | phosphothiophosphoric acid-adenylate ester | Human | 15653 | |
| ATR | PIKK | Atypical | 9zcy | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15654 | |
| ATR | PIKK | Atypical | 9zd3 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15655 | |
| ATR | PIKK | Atypical | 26zn | A | | phosphothiophosphoric acid-adenylate ester | Human | 15656 | |
| ATR | PIKK | Atypical | 23fe | A | | phosphothiophosphoric acid-adenylate ester | Human | 15657 | |
| ATR | PIKK | Atypical | 5yz0 | B | | - | Human | 9524 | |
| ATR | PIKK | Atypical | 9l4b | A | | camonsertib | Human | 15658 | |
| PIK3CA (p110a) | PIK | Atypical | 7myo | B | A | - | Human | 13962 | |
| PIK3CA (p110a) | PIK | Atypical | 5fi4 | A | A | ~{n}-[6-[5-azanyl-6-[(2~{s})-1,1,1-tris(fluoranyl)propan-2-yl]oxy-pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]ethanamide | Human | 9302 | |
| PIK3CA (p110a) | PIK | Atypical | 6oac | A | | 4-(difluoromethyl)-5-{4-[(3s)-3-methylmorpholin-4-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}pyridin-2-amine | Human | 11381 | |
| PIK3CA (p110a) | PIK | Atypical | 4tuu | A | | - | Human | 9281 | |
| PIK3CA (p110a) | PIK | Atypical | 5ul1 | A | B | 3-amino-6-(4-{[(2s)-1-(dimethylamino)propan-2-yl]sulfonyl}phenyl)-n-phenylpyrazine-2-carboxamide | Human | 9308 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxf | A | | - | Human | 9284 | |
| PIK3CA (p110a) | PIK | Atypical | 8tdu | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14969 | |
| PIK3CA (p110a) | PIK | Atypical | 8ts8 | A | | - | Human | 15086 | |
| PI4K2A | PIK | Atypical | 4hne | A | | adenosine-5'-diphosphate | Human | 9262 | |
| PI4KB | PIK | Atypical | 5fbq | A | | ~{n}-[2-[[6-chloranyl-3-[3-[4-(hydroxymethyl)piperidin-1-yl]sulfonyl-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide | Human | 9131 | |
| PIK3CA (p110a) | PIK | Atypical | 7jiu | A | B | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | 13761 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxe | A | | - | Human | 9280 | |
| PIK3CA (p110a) | PIK | Atypical | 5xgh | A | | 3-[(4-fluorophenyl)methylamino]-5-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | Human | 9864 | |
| PIK3CA (p110a) | PIK | Atypical | 4waf | A | A | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | 9288 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxk | A | | - | Human | 9296 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6m | A | B | 2,2-difluoroethyl (3s)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Human | 13227 | |
| PIK3CA (p110a) | PIK | Atypical | 7r9y | A | | n-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-n-methyl-1-(prop-2-enoyl)piperidine-4-carboxamide | Human | 14179 | |
| PIK3CA (p110a) | PIK | Atypical | 3hhm | A | | (1s,6br,9as,11r,11br)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3h-furo[4,3,2-de]indeno[4,5-h][2]benzopyran-11-yl acetate | Human | 9275 | |
| MTOR (FRAP) | PIKK | Atypical | 7uxc | A | | - | Human | 14525 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsv | A | | adenosine-5'-diphosphate | Human | 9109 | |
| MTOR (FRAP) | PIKK | Atypical | 6sb2 | B | | - | Human | 11726 | |
| MTOR (FRAP) | PIKK | Atypical | 7peb | A | | - | Human | 13869 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsx | B | | 9-(6-aminopyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2(1h)-one | Human | 9111 | |
| MTOR (FRAP) | PIKK | Atypical | 9f45 | A | | - | Human | 15315 | |
| MTOR (FRAP) | PIKK | Atypical | 5h64 | a | | - | Human | 9110 | |
| PIK3CD (p110d) | PIK | Atypical | 7lq1 | A | | n-(5-(6-(2-((2s,6r)-2,6-dimethylmorpholino)pyridin-4-yl)-1-oxoisoindolin-4-yl)-2-methoxypyridin-3-yl)methanesulfonamide | Human | 14106 | |
| RIOK2 | RIO | Atypical | 6fdm | A | B | phosphoaminophosphonic acid-adenylate ester | Human | 10877 | |
| RIOK2 | RIO | Atypical | 6fdm | D | B | - | Human | 10872 | |
| RIOK2 | RIO | Atypical | 6hk6 | G | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10640 | |
| RIOK2 | RIO | Atypical | 6g51 | v | | - | Human | 9985 | |
| RIOK2 | RIO | Atypical | 6hk6 | H | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10632 | |
| RIOK2 | RIO | Atypical | 6fdo | B | | - | Human | 10870 | |
| PIK3CG (p110g) | PIK | Atypical | 8sc8 | A | A | n-[(5p)-2-chloro-5-(4-{[(1r)-1-phenylethyl]amino}quinazolin-6-yl)pyridin-3-yl]methanesulfonamide | Human | 15289 | |
| PIK3CG (p110g) | PIK | Atypical | 8sc8 | A | C | n-[(5p)-2-chloro-5-(4-{[(1r)-1-phenylethyl]amino}quinazolin-6-yl)pyridin-3-yl]methanesulfonamide | Human | 15290 | |
| PIK3CG (p110g) | PIK | Atypical | 8sc8 | A | B | n-[(5p)-2-chloro-5-(4-{[(1r)-1-phenylethyl]amino}quinazolin-6-yl)pyridin-3-yl]methanesulfonamide | Human | 15291 | |
| PIK3CG (p110g) | PIK | Atypical | 4fhk | A | | 3-[2-methyl-6-(pyrazin-2-ylamino)pyrimidin-4-yl]-n-(1h-pyrazol-3-yl)imidazo[1,2-b]pyridazin-2-amine | Human | 9204 | |
| PIK3CG (p110g) | PIK | Atypical | 1e8y | A | | - | Human | 9248 | |
| PIK3CG (p110g) | PIK | Atypical | 3ml8 | A | | 8-cyclopentyl-6-[3-(hydroxymethyl)phenyl]-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9192 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxj | A | | - | Human | 9301 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxt | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 9299 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw5 | A | B | - | Human | 16019 | |
| PIK3CA (p110a) | PIK | Atypical | 5xgj | A | | 3-(4-morpholin-4-ylfuro[3,2-d]pyrimidin-2-yl)-5-[(phenylmethyl)amino]phenol | Human | 9863 | |
| PIK3CA (p110a) | PIK | Atypical | 8ow2 | A | B | - | Human | 14764 | |
| PIK3CA (p110a) | PIK | Atypical | 9b4s | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 16024 | |
| PIK3CA (p110a) | PIK | Atypical | 8dcp | A | A | - | Human | 14380 | |
| PIK3CA (p110a) | PIK | Atypical | 5swt | A | | - | Human | 9273 | |
| PIK3CA (p110a) | PIK | Atypical | 4zop | A | A | (2s,3r)-n~1~-(8-tert-butyl-4,5-dihydro[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide | Human | 9298 | |
| PIK3CA (p110a) | PIK | Atypical | 5xgi | A | | 3-azanyl-5-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | Human | 9865 | |
| PIK3CA (p110a) | PIK | Atypical | 5swp | A | | - | Human | 9293 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxd | A | | - | Human | 9304 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw7 | A | B | - | Human | 16025 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxh | A | | methyl {2-[4-(2-chlorophenyl)-4h-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepin-8-yl}carbamate | Human | 9310 | |
| PIK3CA (p110a) | PIK | Atypical | 4zop | A | B | (2s,3r)-n~1~-(8-tert-butyl-4,5-dihydro[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide | Human | 9312 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbc | A | B | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1h-imidazo[4,5-b]pyridine | Human | 14842 | |
| PIK3CA (p110a) | PIK | Atypical | 7myo | B | B | - | Human | 13965 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg6 | A | B | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14349 | |
| PIK3CA (p110a) | PIK | Atypical | 4ykn | A | A | 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid | Human | 9283 | |
| PIK3CA (p110a) | PIK | Atypical | 6nct | A | | - | Human | 11221 | |
| PIK3CA (p110a) | PIK | Atypical | 8ilr | A | B | n-[(2s)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | 14973 | |
| PIK3CA (p110a) | PIK | Atypical | 9nid | A | | - | Human | 16026 | |
| PIK3CA (p110a) | PIK | Atypical | 9nlc | A | | - | Human | 16027 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw8 | A | A | - | Human | 16028 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw5 | A | A | - | Human | 16029 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k1n | A | | - | Human | 13210 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 5luq | A | | - | Human | 9321 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k1k | A | | - | Human | 13211 | |
| TRRAP | PIKK | Atypical | 8h7g | A | | - | Human | 14556 | |
| TRRAP | PIKK | Atypical | 8xvg | A | A | adenosine-5'-diphosphate | Human | 15321 | |
| TRRAP | PIKK | Atypical | 8qri | A | | - | Human | 15322 | |
| RIOK1 | RIO | Atypical | 6zv6 | I | A | - | Human | 13546 | |
| RIOK1 | RIO | Atypical | 6zv6 | I | B | - | Human | 13545 | |
| RIOK1 | RIO | Atypical | 6zxf | z | | adenosine-5'-triphosphate | Human | 13010 | |
| RIOK1 | RIO | Atypical | 6zxe | z | | - | Human | 13011 | |
| RIOK1 | RIO | Atypical | 4otp | A | | adenosine-5'-diphosphate | Human | 9156 | |
| RIOK1 | RIO | Atypical | 6zxg | z | | adenosine-5'-triphosphate | Human | 13012 | |
| RIOK1 | RIO | Atypical | 6zxd | z | | - | Human | 13013 | |
| PIK3CG (p110g) | PIK | Atypical | 4aof | A | | n-[6-(5-methylsulfonylpyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]ethanamide | Human | 9245 | |
| PIK3CG (p110g) | PIK | Atypical | 4wwo | A | | n-{(1s)-1-[8-chloro-2-(3-fluorophenyl)quinolin-3-yl]ethyl}-9h-purin-6-amine | Human | 9190 | |
| PIK3CG (p110g) | PIK | Atypical | 4kz0 | A | | methyl 2-(acetylamino)-1,3-benzothiazole-6-carboxylate | Human | 9161 | |
| PIK3CG (p110g) | PIK | Atypical | 5jhb | A | | [1-{4-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}-3-(chloromethyl)azetidin-3-yl]methanol | Human | 9238 | |
| PIK3CG (p110g) | PIK | Atypical | 3l13 | A | | [3-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenyl]methanol | Human | 9167 | |
| PIK3CG (p110g) | PIK | Atypical | 7z61 | A | | 9-[(3~{r},4~{r})-4-fluoranylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one | Human | 14286 | |
| PIK3CG (p110g) | PIK | Atypical | 4anw | A | A | 3-amino-6-{4-chloro-3-[(2,3-difluorophenyl)sulfamoyl]phenyl}-n-methylpyrazine-2-carboxamide | Human | 9174 | |
| PIK3CG (p110g) | PIK | Atypical | 7kke | A | | n-[2-(3,3-dimethylbutoxy)ethyl]-n'-{4-methyl-5-[(pyridin-4-yl)ethynyl]-1,3-thiazol-2-yl}urea | Human | 13433 | |
| PIK3CG (p110g) | PIK | Atypical | 3ml9 | A | | 2-amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9187 | |
| PIK3CG (p110g) | PIK | Atypical | 3l08 | A | B | 2,4-difluoro-n-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide | Human | 9164 | |
| PIK3CG (p110g) | PIK | Atypical | 3p2b | A | B | 3-[2-morpholin-4-yl-6-(pyridin-3-ylamino)pyrimidin-4-yl]phenol | Human | 9165 | |
| PIK3CG (p110g) | PIK | Atypical | 3p2b | A | A | 3-[2-morpholin-4-yl-6-(pyridin-3-ylamino)pyrimidin-4-yl]phenol | Human | 9169 | |
| PIK3CG (p110g) | PIK | Atypical | 4fa6 | A | | 2-amino-8-cyclopentyl-4-methyl-6-(1h-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9191 | |
| PIK3CG (p110g) | PIK | Atypical | 4ezj | A | | 2-(1-{[2-(5-fluoro-1h-indol-4-yl)-4-(morpholin-4-yl)pyrido[3,2-d]pyrimidin-6-yl]methyl}piperidin-4-yl)propan-2-ol | Human | 9222 | |
| PIK3CG (p110g) | PIK | Atypical | 4fad | A | | 2-amino-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methyl-8-(pyrrolidin-1-yl)pyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9202 | |
| PIK3CG (p110g) | PIK | Atypical | 2chx | A | | n-(2,3-dihydro-7,8-dimethoxyimidazo[1,2-c] quinazolin-5-yl)nicotinamide | Human | 9247 | |
| PIK3CG (p110g) | PIK | Atypical | 4f1s | A | | n-(5-{[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(tetrahydro-2h-pyran-4-yl)pyridin-2-yl]amino}-2-chloropyridin-3-yl)methanesulfonamide | Human | 9221 | |
| PIK3CG (p110g) | PIK | Atypical | 5eds | A | | 4-azanyl-6-[[(1~{s})-1-[6-fluoranyl-1-(3-methylsulfonylphenyl)benzimidazol-2-yl]ethyl]amino]pyrimidine-5-carbonitrile | Human | 9208 | |
| PIK3CG (p110g) | PIK | Atypical | 3csf | A | | - | Human | 9215 | |
| PIK3CG (p110g) | PIK | Atypical | 3l17 | A | | 4-methyl-5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine | Human | 9185 | |
| PIK3CG (p110g) | PIK | Atypical | 2a4z | A | | (5e)-5-[(2,2-difluoro-1,3-benzodioxol-5-yl)methylene]-1,3-thiazolidine-2,4-dione | Human | 9180 | |
| PIK3CG (p110g) | PIK | Atypical | 7jwz | A | | 2-amino-n-[(1s)-1-{8-[(1-methyl-1h-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl}ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide | Human | 13410 | |
| PIK3CG (p110g) | PIK | Atypical | 3tjp | A | | n~6~-(3,4-dimethoxyphenyl)-2-(morpholin-4-yl)-4,5'-bipyrimidine-2',6-diamine | Human | 9234 | |
| PIK3CG (p110g) | PIK | Atypical | 3nzu | A | | 6-(2h-indazol-4-yl)-1-methyl-n-[3-(methylsulfonyl)propyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 9177 | |
| PIK3CG (p110g) | PIK | Atypical | 4j6i | A | | 2-methyl-1-(4-{2-[1-(2,2,2-trifluoroethyl)-1h-1,2,4-triazol-5-yl]-4,5-dihydro[1]benzoxepino[5,4-d][1,3]thiazol-8-yl}-1h-pyrazol-1-yl)propan-2-ol | Human | 9189 | |
| PIK3CG (p110g) | PIK | Atypical | 4hvb | A | | 1-{1-[(2s)-2-hydroxypropanoyl]piperidin-4-yl}-3-methyl-8-(6-methylpyridin-3-yl)-1,3-dihydro-2h-imidazo[4,5-c][1,5]naphthyridin-2-one | Human | 9225 | |
| PIK3CG (p110g) | PIK | Atypical | 3s2a | A | | n-{2-chloro-5-[4-(morpholin-4-yl)quinolin-6-yl]pyridin-3-yl}-4-fluorobenzenesulfonamide | Human | 9158 | |
| PIK3CG (p110g) | PIK | Atypical | 4ful | A | | 4-({4-[3-(piperidin-1-ylcarbonyl)phenyl]pyrimidin-2-yl}amino)benzenesulfonamide | Human | 9242 | |
| PIK3CG (p110g) | PIK | Atypical | 4wwn | A | | n-{(1s)-1-[7-fluoro-2-(pyridin-2-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine | Human | 9226 | |
| PIK3CG (p110g) | PIK | Atypical | 5oq4 | A | B | 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | Human | 9203 | |
| PIK3CG (p110g) | PIK | Atypical | 3dbs | A | | 2-(1h-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-yl-thieno[3,2-d]pyrimidine | Human | 9230 | |
| PIK3CG (p110g) | PIK | Atypical | 6aud | A | A | 10-[(s)-(1-tert-butylpiperidin-4-yl)sulfinyl]-2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | Human | 9239 | |
| PIK3CG (p110g) | PIK | Atypical | 6t3b | A | | 2-[(4-methoxy-2-methyl-phenyl)amino]-7-methyl-9-(4-oxidanylcyclohexyl)purin-8-one | Human | 11906 | |
| PIK3CG (p110g) | PIK | Atypical | 3r7r | A | | 8-(acetylamino)-n-(2-chlorophenyl)-n-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide | Human | 9168 | |
| PIK3CG (p110g) | PIK | Atypical | 4anv | A | B | 2-{4-[(4'-methoxybiphenyl-3-yl)sulfonyl]piperazin-1-yl}-3-(4-methoxyphenyl)pyrazine | Human | 9166 | |
| PIK3CG (p110g) | PIK | Atypical | 4fjy | A | | 4-[3,3-dimethyl-6-(morpholin-4-yl)-2,3-dihydro-1h-indol-1-yl]-7-fluoro-3-methyl-2-(pyridin-3-yl)quinoline | Human | 9249 | |
| PIK3CG (p110g) | PIK | Atypical | 3apf | A | | 3-[7-(1h-benzimidazol-5-yl)-2-(morpholin-4-yl)-6,7-dihydro-5h-pyrrolo[2,3-d]pyrimidin-4-yl]phenol | Human | 9250 | |
| PIK3CG (p110g) | PIK | Atypical | 2a5u | A | | (5e)-5-(quinoxalin-6-ylmethylene)-1,3-thiazolidine-2,4-dione | Human | 9183 | |
| PIK3CG (p110g) | PIK | Atypical | 4ps3 | A | | 1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1h-imidazol-4-yl)ethyl]urea | Human | 9193 | |
| PIK3CG (p110g) | PIK | Atypical | 6gq7 | A | | 3-methyl-1-(oxan-4-yl)-8-pyridin-3-yl-imidazo[4,5-c]quinolin-2-one | Human | 10009 | |
| PIK3CG (p110g) | PIK | Atypical | 3mjw | A | | (2z)-4,6-dihydroxy-2-[(8-methoxy-1,2,3,4-tetrahydropyrazino[1,2-a]indol-10-yl)methylidene]-1-benzofuran-3(2h)-one | Human | 9229 | |
| PIK3CG (p110g) | PIK | Atypical | 3qjz | A | | n-{6-[2-(methylsulfanyl)pyrimidin-4-yl]-1,3-benzothiazol-2-yl}acetamide | Human | 9181 | |
| PIK3CG (p110g) | PIK | Atypical | 4gb9 | A | | 2-[1-({2-[2-(dimethylamino)-1h-benzimidazol-1-yl]-9-methyl-6-(morpholin-4-yl)-9h-purin-8-yl}methyl)piperidin-4-yl]propan-2-ol | Human | 9218 | |
| PIK3CG (p110g) | PIK | Atypical | 4hle | A | | 2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide | Human | 9219 | |
| PIK3CD (p110d) | PIK | Atypical | 6g6w | A | B | ~{n}-[3-[4-[[(1~{s})-1-(5-methyl-4-oxidanylidene-3-phenyl-pyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino]-7~{h}-pyrrolo[2,3-d]pyrimidin-5-yl]-5-oxidanyl-phenyl]methanesulfonamide | Human | 10674 | |
| PIK3CD (p110d) | PIK | Atypical | 7jis | A | | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | 13201 | |
| PIK3CD (p110d) | PIK | Atypical | 6g6w | A | A | ~{n}-[3-[4-[[(1~{s})-1-(5-methyl-4-oxidanylidene-3-phenyl-pyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino]-7~{h}-pyrrolo[2,3-d]pyrimidin-5-yl]-5-oxidanyl-phenyl]methanesulfonamide | Human | 10673 | |
| PIK3CD (p110d) | PIK | Atypical | 9gdi | A | | 3-[(1s)-1-[4-azanyl-3-(3-fluoranyl-5-oxidanyl-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-4-(1-methyl-3,6-dihydro-2h-pyridin-4-yl)isochromen-1-one | Human | 15480 | |
| PIK3CD (p110d) | PIK | Atypical | 7lm2 | A | | cyclopropyl[(3s)-3-{[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]amino}pyrrolidin-1-yl]methanone | Human | 13532 | |
| PIK3CD (p110d) | PIK | Atypical | 5vlr | A | | 4-acetyl-1-(3-{4-amino-5-[1-(2,2,2-trifluoroethyl)-1h-pyrazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)-3,3-dimethylpiperazin-2-one | Human | 9090 | |
| PIK3CD (p110d) | PIK | Atypical | 5t8f | A | | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 9093 | |
| PIK3CD (p110d) | PIK | Atypical | 6pyu | A | | (3s)-1'-(cyclopropanecarbonyl)-5-(quinoxalin-6-yl)spiro[indole-3,2'-pyrrolidin]-2(1h)-one | Human | 11548 | |
| PIK3CD (p110d) | PIK | Atypical | 6oco | A | | 4-[(1s,4s)-5-(3-chlorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(pyridin-3-yl)pyrimidine-5-carbonitrile | Human | 11865 | |
| PIK3CD (p110d) | PIK | Atypical | 8bcy | A | A | 9-[2-(3,4-dichlorophenyl)ethyl]-2-(3-hydroxyphenyl)-8-oxidanylidene-7~{h}-purine-6-carboxamide | Human | 14735 | |
| PIK3C3 | PIK | Atypical | 6ykg | A | | 4-morpholin-4-yl-6-[(2~{r})-2-(phenylmethyl)pyrrolidin-1-yl]-1~{h}-pyridin-2-one | Human | 13509 | |
| PIK3C3 | PIK | Atypical | 4uwg | A | B | - | Human | 9350 | |
| PIK3C3 | PIK | Atypical | 7rsj | A | A | n-{4-[(7r,8r)-4-oxo-7-(propan-2-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl]pyridin-2-yl}cyclopropanecarboxamide | Human | 13983 | |
| PIK3C3 | PIK | Atypical | 9tw2 | A | | - | Human | 15515 | |
| PIK3C3 | PIK | Atypical | 9rx4 | A | | - | Human | 15516 | |
| PIK3C3 | PIK | Atypical | 7rsv | A | B | (5as,8ar,9s)-2-[(3r)-3-methylmorpholin-4-yl]-5,5a,6,7,8,8a-hexahydro-4h-cyclopenta[e]pyrazolo[1,5-a]pyrazin-4-one | Human | 13984 | |
| PI4KB | PIK | Atypical | 4d0l | E | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9139 | |
| PI4KB | PIK | Atypical | 4d0m | W | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9155 | |
| PI4KB | PIK | Atypical | 8q6f | A | B | 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-2,5-dimethyl-7-(pyridin-4-ylmethylamino)pyrazolo[1,5-a]pyrimidine | Human | 15013 | |
| PI4KB | PIK | Atypical | 5c46 | E | | - | Human | 9141 | |
| PI4KB | PIK | Atypical | 4d0m | c | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9148 | |
| PI4KB | PIK | Atypical | 4d0m | O | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9154 | |
| PI4KB | PIK | Atypical | 5c4g | E | | n~2~-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]-n-methylglycinamide | Human | 9135 | |
| PI4KB | PIK | Atypical | 4wag | A | | 6-chloro-3-(3,4-dimethoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine | Human | 9137 | |
| PI4KB | PIK | Atypical | 8q6f | A | A | 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-2,5-dimethyl-7-(pyridin-4-ylmethylamino)pyrazolo[1,5-a]pyrimidine | Human | 15018 | |
| PI4KB | PIK | Atypical | 4d0m | G | | n-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide | Human | 9134 | |
| PI4KB | PIK | Atypical | 6gl3 | B | | - | Human | 10443 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7nfe | A | | - | Human | 13851 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7otw | A | | 7-methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one | Human | 14056 | |
| ATR | PIKK | Atypical | 23ey | A | | elimusertib | Human | 15645 | |
| ATR | PIKK | Atypical | 9l40 | A | | ve-822 | Human | 15646 | |
| ATR | PIKK | Atypical | 23fa | A | | gartisertib | Human | 15647 | |
| ATR | PIKK | Atypical | 23ex | A | | ceralasertib | Human | 15648 | |
| ATR | PIKK | Atypical | 5yz0 | A | | - | Human | 9523 | |
| ATR | PIKK | Atypical | 9l45 | A | | ve-822 | Human | 15649 | |
| ATR | PIKK | Atypical | 23ew | A | | ve-822 | Human | 15650 | |
| ATR | PIKK | Atypical | 13de | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15651 | |
| ATR | PIKK | Atypical | 9zd4 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15652 | |
| ATR | PIKK | Atypical | 23fb | A | | phosphothiophosphoric acid-adenylate ester | Human | 15659 | |
| ATR | PIKK | Atypical | 9l4f | A | | phosphothiophosphoric acid-adenylate ester | Human | 15660 | |
| ATR | PIKK | Atypical | 9l46 | A | | phosphothiophosphoric acid-adenylate ester | Human | 15661 | |
| MTOR (FRAP) | PIKK | Atypical | 9t94 | A | | adenosine-5'-triphosphate | Human | 15763 | |
| MTOR (FRAP) | PIKK | Atypical | 9ed8 | A | | phosphoaminophosphonic acid-adenylate ester | Human | 15764 | |
| MTOR (FRAP) | PIKK | Atypical | 7pe8 | A | | - | Human | 13870 | |
| MTOR (FRAP) | PIKK | Atypical | 9f44 | A | | - | Human | 15316 | |
| MTOR (FRAP) | PIKK | Atypical | 6sb0 | A | | - | Human | 11727 | |
| MTOR (FRAP) | PIKK | Atypical | 3jbz | A | | adenosine-5'-diphosphate | Human | 9113 | |
| MTOR (FRAP) | PIKK | Atypical | 7pe9 | A | | - | Human | 13871 | |
| MTOR (FRAP) | PIKK | Atypical | 4jt5 | A | | 2-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-1h-indol-5-ol | Human | 9116 | |
| MTOR (FRAP) | PIKK | Atypical | 8era | A | | 1-[6-{[(3m)-4-amino-3-(2-amino-1,3-benzoxazol-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]methyl}-3,4-dihydroisoquinolin-2(1h)-yl]-3-hydroxypropan-1-one | Human | 14569 | |
| MTOR (FRAP) | PIKK | Atypical | 6zwo | B | | phosphothiophosphoric acid-adenylate ester | Human | 12987 | |
| MTOR (FRAP) | PIKK | Atypical | 7pe7 | A | | - | Human | 13901 | |
| MTOR (FRAP) | PIKK | Atypical | 4jt6 | B | | 3-(4-morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol | Human | 9102 | |
| MTOR (FRAP) | PIKK | Atypical | 5h64 | A | | - | Human | 9099 | |
| MTOR (FRAP) | PIKK | Atypical | 6sb2 | A | | - | Human | 11724 | |
| MTOR (FRAP) | PIKK | Atypical | 5flc | B | B | - | Human | 9108 | |
| MTOR (FRAP) | PIKK | Atypical | 6sb0 | B | | - | Human | 11725 | |
| MTOR (FRAP) | PIKK | Atypical | 5wbu | A | | - | Human | 9407 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsv | B | | adenosine-5'-diphosphate | Human | 9100 | |
| MTOR (FRAP) | PIKK | Atypical | 4jt6 | A | | 3-(4-morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol | Human | 9103 | |
| MTOR (FRAP) | PIKK | Atypical | 5zcs | A | | - | Human | 9748 | |
| MTOR (FRAP) | PIKK | Atypical | 6zwm | B | | phosphothiophosphoric acid-adenylate ester | Human | 12988 | |
| MTOR (FRAP) | PIKK | Atypical | 5wby | B | | - | Human | 9406 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsp | B | | phosphothiophosphoric acid-adenylate ester | Human | 9107 | |
| MTOR (FRAP) | PIKK | Atypical | 4jt5 | B | | 2-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-1h-indol-5-ol | Human | 9104 | |
| MTOR (FRAP) | PIKK | Atypical | 6zwm | A | | phosphothiophosphoric acid-adenylate ester | Human | 12989 | |
| MTOR (FRAP) | PIKK | Atypical | 5flc | F | B | - | Human | 9117 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsx | A | | 9-(6-aminopyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2(1h)-one | Human | 9112 | |
| MTOR (FRAP) | PIKK | Atypical | 5wby | A | | - | Human | 9404 | |
| MTOR (FRAP) | PIKK | Atypical | 7pec | A | | - | Human | 13872 | |
| MTOR (FRAP) | PIKK | Atypical | 5flc | B | A | - | Human | 9105 | |
| MTOR (FRAP) | PIKK | Atypical | 7pea | A | | - | Human | 13873 | |
| MTOR (FRAP) | PIKK | Atypical | 5wbu | B | | - | Human | 9405 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsn | B | | - | Human | 9115 | |
| MTOR (FRAP) | PIKK | Atypical | 4jsn | A | | - | Human | 9114 | |
| MTOR (FRAP) | PIKK | Atypical | 7tzo | A | | - | Human | 14575 | |
| MTOR (FRAP) | PIKK | Atypical | 5flc | F | A | - | Human | 9101 | |
| RIOK2 | RIO | Atypical | 6hk6 | C | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10639 | |
| RIOK2 | RIO | Atypical | 6hk6 | F | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10637 | |
| RIOK2 | RIO | Atypical | 6fdn | A | | - | Human | 10873 | |
| PI4K2B | PIK | Atypical | 4wtv | A | A | adenosine-5'-triphosphate | Human | 9095 | |
| RIOK2 | RIO | Atypical | 6fdn | B | | - | Human | 10867 | |
| RIOK2 | RIO | Atypical | 6fdm | A | A | phosphoaminophosphonic acid-adenylate ester | Human | 10875 | |
| RIOK2 | RIO | Atypical | 6fdm | D | A | - | Human | 10868 | |
| RIOK2 | RIO | Atypical | 6hk6 | E | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10633 | |
| RIOK2 | RIO | Atypical | 6hk6 | B | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10636 | |
| RIOK2 | RIO | Atypical | 6fdm | B | A | - | Human | 10869 | |
| RIOK2 | RIO | Atypical | 7vbt | A | | 8-(6-methoxypyridin-3-yl)-1-[4-piperazin-1-yl-3-(trifluoromethyl)phenyl]-5h-[1,2,3]triazolo[4,5-c]quinolin-4-one | Human | 14274 | |
| RIOK2 | RIO | Atypical | 6fdo | A | | - | Human | 10878 | |
| RIOK2 | RIO | Atypical | 6fdm | B | B | - | Human | 10871 | |
| RIOK2 | RIO | Atypical | 6g18 | v | | - | Human | 9986 | |
| RIOK2 | RIO | Atypical | 6hk6 | A | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10638 | |
| RIOK2 | RIO | Atypical | 6hk6 | I | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10631 | |
| RIOK2 | RIO | Atypical | 6fdm | C | A | phosphoaminophosphonic acid-adenylate ester | Human | 10874 | |
| RIOK2 | RIO | Atypical | 6fdm | C | B | phosphoaminophosphonic acid-adenylate ester | Human | 10876 | |
| RIOK2 | RIO | Atypical | 6hk6 | D | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10634 | |
| RIOK2 | RIO | Atypical | 6hk6 | J | | 2-naphthalen-2-yl-~{n}-pyridin-2-yl-ethanamide | Human | 10635 | |
| RIOK2 | RIO | Atypical | 9f81 | A | | n-(4-quinazolin-4-ylphenyl)propanamide | Human | 15836 | |
| RIOK1 | RIO | Atypical | 6zxh | z | | adenosine-5'-triphosphate | Human | 13073 | |
| COQ8A (ADCK3) | ABC1 | Atypical | 7udq | A | | 4-[(3,4,5-trimethoxyphenyl)amino]quinoline-7-carbonitrile | Human | 14588 | |
| COQ8A (ADCK3) | ABC1 | Atypical | 7udp | A | | 4-[(3,4,5-trimethoxyphenyl)amino]quinoline-7-carbonitrile | Human | 14589 | |
| PIK3CA (p110a) | PIK | Atypical | 9lws | A | | - | Human | 16011 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvi | A | A | 3-(2-azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine | Human | 11656 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni8 | A | | - | Human | 16007 | |
| PIK3CA (p110a) | PIK | Atypical | 5itd | A | | 5-{4-[3-(4-acetylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl}-2-methoxypyridine-3-carbonitrile | Human | 9313 | |
| PIK3CA (p110a) | PIK | Atypical | 8tdu | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14967 | |
| PIK3CA (p110a) | PIK | Atypical | 5sx9 | A | | - | Human | 9305 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbj | A | A | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(1h-pyrazol-3-yl)-3h-imidazo[4,5-b]pyridine | Human | 14839 | |
| PIK3CA (p110a) | PIK | Atypical | 9cmv | A | | - | Human | 16008 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvi | A | B | 3-(2-azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine | Human | 11654 | |
| PIK3CA (p110a) | PIK | Atypical | 4l1b | A | | - | Human | 9292 | |
| PIK3CA (p110a) | PIK | Atypical | 8bfu | A | | - | Human | 14613 | |
| PIK3CA (p110a) | PIK | Atypical | 8dd8 | A | | - | Human | 14375 | |
| PIK3CA (p110a) | PIK | Atypical | 9lwr | A | A | - | Human | 16009 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6n | A | B | tert-butyl (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate | Human | 13224 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvf | A | B | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11658 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvf | A | A | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11659 | |
| PIK3CA (p110a) | PIK | Atypical | 7myn | A | A | - | Human | 13963 | |
| PIK3CA (p110a) | PIK | Atypical | 8am0 | A | | (2r)-2-[[2-[(4s)-4-[bis(fluoranyl)methyl]-2-oxidanylidene-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide | Human | 15083 | |
| PIK3CA (p110a) | PIK | Atypical | 5swg | A | | - | Human | 9306 | |
| PIK3CA (p110a) | PIK | Atypical | 7r9v | A | | n-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide | Human | 14178 | |
| PIK3CA (p110a) | PIK | Atypical | 5swr | A | | - | Human | 9279 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni7 | A | | - | Human | 16010 | |
| PIK3CA (p110a) | PIK | Atypical | 7k71 | A | | 2-(morpholin-4-yl)[4,5'-bipyrimidin]-2'-amine | Human | 13219 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg5 | A | A | - | Human | 14346 | |
| PIK3CA (p110a) | PIK | Atypical | 8dcp | A | B | - | Human | 14376 | |
| PIK3CA (p110a) | PIK | Atypical | 5ul1 | A | A | 3-amino-6-(4-{[(2s)-1-(dimethylamino)propan-2-yl]sulfonyl}phenyl)-n-phenylpyrazine-2-carboxamide | Human | 9316 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6o | A | B | (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-n-methylpyrrolidine-1-sulfonamide | Human | 13206 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg5 | A | B | - | Human | 14347 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbj | A | B | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(1h-pyrazol-3-yl)-3h-imidazo[4,5-b]pyridine | Human | 14840 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxa | A | | - | Human | 9285 | |
| PIK3CA (p110a) | PIK | Atypical | 9b4t | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 16012 | |
| PIK3CA (p110a) | PIK | Atypical | 7jiu | A | A | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | 13760 | |
| PIK3CA (p110a) | PIK | Atypical | 4waf | A | B | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | 9272 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvh | A | A | 5-(6-azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11657 | |
| PIK3CA (p110a) | PIK | Atypical | 8exl | A | B | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 14536 | |
| PIK3CA (p110a) | PIK | Atypical | 5ubr | A | | 1-[4-(3-{4-amino-5-[1-(oxan-4-yl)-1h-pyrazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)piperazin-1-yl]ethan-1-one | Human | 9289 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6m | A | A | 2,2-difluoroethyl (3s)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Human | 13225 | |
| PIK3CA (p110a) | PIK | Atypical | 4jps | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 9317 | |
| PIK3CA (p110a) | PIK | Atypical | 8dcx | A | | - | Human | 14377 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni5 | A | | - | Human | 16013 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw7 | A | A | - | Human | 16014 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6n | A | A | tert-butyl (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate | Human | 13226 | |
| PIK3CA (p110a) | PIK | Atypical | 3zim | A | | 1-[4-[[2-(1h-indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methyl-hept-5-ene-1,4-dione | Human | 9294 | |
| PIK3CA (p110a) | PIK | Atypical | 5sw8 | A | | - | Human | 9274 | |
| PIK3CA (p110a) | PIK | Atypical | 4tv3 | A | | 2-amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9278 | |
| PIK3CA (p110a) | PIK | Atypical | 5uk8 | A | A | (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine | Human | 9295 | |
| PIK3CA (p110a) | PIK | Atypical | 5ukj | A | | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | 9277 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6o | A | A | (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-n-methylpyrrolidine-1-sulfonamide | Human | 13207 | |
| PIK3CA (p110a) | PIK | Atypical | 2rd0 | A | | - | Human | 9287 | |
| PIK3CA (p110a) | PIK | Atypical | 4l23 | A | | 3-(4-morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol | Human | 9290 | |
| PIK3CA (p110a) | PIK | Atypical | 6pys | A | A | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | 11575 | |
| PIK3CA (p110a) | PIK | Atypical | 4l2y | A | | 3-amino-5-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol | Human | 9276 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvg | A | | 5-(6-azanyl-4-methyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11655 | |
| PIK3CA (p110a) | PIK | Atypical | 7tz7 | A | B | (4s,5r)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one | Human | 14222 | |
| PIK3CA (p110a) | PIK | Atypical | 3hiz | A | | - | Human | 9311 | |
| PIK3CA (p110a) | PIK | Atypical | 9nie | A | | - | Human | 16015 | |
| PIK3CA (p110a) | PIK | Atypical | 4jps | A | B | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 9314 | |
| PIK3CA (p110a) | PIK | Atypical | 8exv | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14538 | |
| PIK3CA (p110a) | PIK | Atypical | 9lwq | A | | - | Human | 16016 | |
| PIK3CA (p110a) | PIK | Atypical | 9yf2 | A | | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 16017 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni3 | A | | - | Human | 16018 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxi | A | | - | Human | 9270 | |
| PIK3CA (p110a) | PIK | Atypical | 4ykn | A | B | 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid | Human | 9315 | |
| PIK3CA (p110a) | PIK | Atypical | 8exu | A | A | (2s)-2-cyclopropyl-2-({(4s,11am)-2-[(4s)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide | Human | 14539 | |
| PIK3CA (p110a) | PIK | Atypical | 8gua | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14540 | |
| PIK3CA (p110a) | PIK | Atypical | 9lwr | A | B | - | Human | 16020 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxh | D | | methyl {2-[4-(2-chlorophenyl)-4h-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepin-8-yl}carbamate | Human | 9300 | |
| PIK3CA (p110a) | PIK | Atypical | 5sx8 | A | | - | Human | 9269 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbc | A | A | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1h-imidazo[4,5-b]pyridine | Human | 14841 | |
| PIK3CA (p110a) | PIK | Atypical | 9nif | A | | - | Human | 16021 | |
| PIK3CA (p110a) | PIK | Atypical | 8tgd | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14972 | |
| PIK3CA (p110a) | PIK | Atypical | 8dd4 | A | A | - | Human | 14378 | |
| PIK3CA (p110a) | PIK | Atypical | 9c15 | A | | - | Human | 16022 | |
| PIK3CA (p110a) | PIK | Atypical | 8dd4 | A | B | - | Human | 14379 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw8 | A | B | - | Human | 16023 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvh | A | B | 5-(6-azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11653 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxc | A | | - | Human | 9297 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni4 | A | | - | Human | 16030 | |
| PIK3CA (p110a) | PIK | Atypical | 8gub | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14543 | |
| PIK3CA (p110a) | PIK | Atypical | 8exu | A | B | (2s)-2-cyclopropyl-2-({(4s,11am)-2-[(4s)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide | Human | 14544 | |
| PIK3CA (p110a) | PIK | Atypical | 5uk8 | A | B | (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine | Human | 9286 | |
| PI4K2A | PIK | Atypical | 4hnd | A | | adenosine-5'-diphosphate | Human | 9265 | |
| PI4K2A | PIK | Atypical | 4hne | B | | adenosine-5'-diphosphate | Human | 9263 | |
| PI4K2A | PIK | Atypical | 4pla | A | | adenosine-5'-triphosphate | Human | 9259 | |
| PI4K2A | PIK | Atypical | 4yc4 | A | | [(1s,3s,4s)-3-(6-amino-9h-purin-9-yl)bicyclo[2.2.1]hept-1-yl]methanol | Human | 9258 | |
| PI4K2A | PIK | Atypical | 4hnd | B | | adenosine-5'-diphosphate | Human | 9261 | |
| PI4K2A | PIK | Atypical | 5i0n | A | B | adenosine-5'-triphosphate | Human | 9257 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 5w1r | A | | - | Human | 9320 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7otp | A | | phosphothiophosphoric acid-adenylate ester | Human | 14054 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zh8 | A | | - | Human | 12925 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 8bh3 | A | | - | Human | 14768 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k1j | A | | - | Human | 13209 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zfp | A | | - | Human | 12926 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k0y | A | A | - | Human | 13213 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 8bhv | A | | - | Human | 14769 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9qcs | A | | - | Human | 16044 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k0y | A | B | - | Human | 13214 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k17 | A | | - | Human | 13215 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7lt3 | C | | adenosine-5'-diphosphate | Human | 13500 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7lt3 | L | | adenosine-5'-diphosphate | Human | 13501 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9zp0 | K | | - | Human | 16045 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 8rd4 | A | | - | Human | 16046 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zh4 | A | | - | Human | 12930 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k19 | A | | - | Human | 13216 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9g9l | A | | - | Human | 16047 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k10 | A | | - | Human | 13217 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9q9f | E | | - | Human | 16048 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 8bhy | A | | - | Human | 14770 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7k1b | A | | - | Human | 13218 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 7tyr | A | A | - | Human | 14322 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 6zhe | F | | - | Human | 12932 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 5y3r | C | | - | Human | 9318 | |
| ANTXR1 (DNAPK) | PIKK | Atypical | 9zp9 | M | | - | Human | 16049 | |
| PI4KA | PIK | Atypical | 6bq1 | E | | 5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1h-benzimidazol-6-yl}-n-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide | Human | 9069 | |
| PI4KA | PIK | Atypical | 6bq1 | A | | 5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1h-benzimidazol-6-yl}-n-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide | Human | 9070 | |
| RIOK3 | RIO | Atypical | 8zdb | J | | - | Human | 16170 | |
| RIOK3 | RIO | Atypical | 8zdc | J | | - | Human | 16171 | |
| ATM | PIKK | Atypical | 5np1 | A | | - | Human | 9268 | |
| ATM | PIKK | Atypical | 7sid | A | | phosphoaminophosphonic acid-adenylate ester | Human | 14102 | |